This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0249U for Theralink® Reverse Phase Protein Array (RPPA) assay by Theralink® Technologies Inc. The test evaluates a breast tumor tissue sample for the quantity and activation of 32 phosphoproteins and proteins that are cell surface receptors targeted by most cancer therapy drugs, and provides an algorithmic analysis and interpretive report that can help guide clinical treatment.
For clinical responsibility, terminology, tips and additional info
start codify free trial.